9:00 am Check-in & Light Breakfast

9:15 am Chair’s Opening Remarks

Translating Novel Microbiome Innovations to the Shelves

9:30 am Deriving a Balance Between Preservatives and Probiotics to Formulate Effective and Safe Products

• Tom Verlinden Chief Executive Officer, YUN

10:00 am Assessing Diverse Translation & Formulation Avenues for Different Microbiome Products

• Sofia Iglesia Senior Scientist - Research & Development, Revision Skincare

10:30 am Morning Networking Break

Evaluating Clinical Outcomes to Redefine Skin Health

11:30 am Lessons Learnt from Ammonia Oxidizing Bacteria Products: Years into Market & Clinical Trials

• Daniel Brownell Senior Director - Research and Development, AOBiome

12:00 pm Highlighting the Potential of Microbiome Products in Treating Skin Conditions: Presenting Efficacy Data from the Clinic

• Milana Shternberg-Anash Chief Executive Officer and Founder, ClearSkin Medical

12:30 pm Utilizing Bacteriophages as a Tool for Precisely Manipulating the Skin Microbiome

• Paul Lawrence Executive Director of Research and Discovery, Biocogent LLC

1:00 pm Lunch

Consumer Trust, Community Vocabulary & Claim Substantiation

2:00 pm Addressing Future Regulatory Challenges to Ensure Effective & Complaint Novel Product Development

• Avril Love Counsel, K&L Gates LLP

2:30 pm Attempting to Define a “Good Microbiome” to Increase Product Trust and Language Consistency

• Larry Weiss Chief Executive Officer and Founder, Symbiome

3:00 pm Panel: Navigating the Challenging Waters of Labelling, Marketing, and Community Language

• Avril Love Counsel, K&L Gates LLP
• Larry Weiss Chief Executive Officer and Founder, Symbiome
• Nyree Bekarian Mack Product Safety Specialist and Strategic Consultant, NBM Consulting
• Apostolos Pappas Senior Dermatology Consultant, Nogra Pharma

3:45 pm Chair’s Closing Remarks

4:00 pm Close of the 7th Microbiome Movement Skin Health & Cosmeceuticals Summit